Vidyya Medical News Servicesm
Vidyya, from the Sanskrit "vaidya," a practitioner who has come to understand the science of life.

Volume 2 Published - 14:00 UTC    08:00 EST    10-January-2001      
Issue 10 Next Update - 14:00 UTC 08:00 EST    11-January-2001      

Vidyya Home  Vidyya

Home Of Our Sponsor, Vidyya.  Vidyya. Home

Vidyya Archives  Vidyya Archives

Search Vidyya  Search Vidyya

Visit Our Library  Ex Libris

Subscribe To Our News Service  Subscriptions

All About Us  About Vidyya




















Back To Vidyya Today In Vidyyasm

Vidyya Medical News Service For 10-January-2001:

The following stories appear in full on today's Vidyya Medical News Service Web site.

MicroMed Technology, Inc. today announced that it received approval from the Food and Drug Administration (FDA) to expand the US MicroMed DeBakey Ventricular Assist Device (VAD) feasibility study from its initial site at The Methodist Hospital in Houston, Texas to three sites and 20 patients.

For more information: FDA Approves Expansion Of The Micromed Debakey VAD® Clinical Trial

Antex Biologics Inc. has announced that a recently completed Phase II clinical trial of Campyvax, a vaccine to prevent Campylobacter infections, showed significant immune responses that correlate with protection against disease. Development of the vaccine is proceeding; the US Department of Defense will support clinical trials through Phase III.

For more information: Campylobacter Vaccine Exhibits Significant Immune Responses In Phase II Clinical Trial

Antibiotic use on the nation's farms dwarfs the use of the life-saving drugs in human medicine and may play a much larger role than expected in promoting the spread of drug-resistant microbes, a new study of US agriculture shows.

For more information: Study Says Overuse Of Antibiotic In Animals Poses Risk To Humans

Mental health disorders ranging from depression to epilepsy, will be the second most common cause of death and disability by 2020, say experts. The World Health Organzation estimates the numbers affected by mental and neurological disorders will surge over the next 20 years.

For more information: The Coming Plague: A Surge In Mental Disorders Predicted

Information about the risks of so-called "economy class syndrome" is to be distributed with tickets by British Airways. The public have become more aware of potentially-fatal deep vein thrombosis following a number of deaths among long-haul airline passengers. Now British Airways is sending out leaflets containing health tips on preventing the illness to anyone booking a long flight. It is also distributing leaflets and posters to GP surgeries.

Blood Clots And Air Travel - A Deadly Mix

Today's Vidyya articles are:

As always, we hope you enjoy the issue.

Vidyya. Home |  Ex Libris |  Vidyya  | 
Subscription Information |  About Vidyya |  Vidyya Archives | 

Editor: Susan K. Boyer, RN
© Vidyya. All rights reserved.